Search

Efrat Eliyahu

from New York, NY
Age ~52
Get Report
Also known as:
Efert Elyahu, Efrat N
Connected to:
Eyal Eliyahu, 53Keren Eliyahu, 48Levi Eliyahu, 60Moshe Eliyahu, 48Mari Eliza, 74Naaman L Eliza, 49Beth Elizabeth, 74Dixon V Elizabeth, 78Flora Elizabeth, 53Hawkins V Elizabeth, 52

Efrat Eliyahu Phones & Addresses

  • New York, NY
  • River Edge, NJ

Work

Company: Icahn school of medicine at mount sinai Jul 2003 Position: Assistant professor

Skills

Biochemistry

Industries

Research

Resumes

Resumes

Efrat Eliyahu Photo 1

Assistant Professor

View page
Location:
New York, NY
Industry:
Research
Work:
Icahn School of Medicine at Mount Sinai
Assistant Professor
Skills:
Biochemistry

Publications

Us Patents

Method To Determine Embryo And Oocyte Quality Based On Ceramidase

View page
US Patent:
20120115158, May 10, 2012
Filed:
May 3, 2010
Appl. No.:
13/318377
Inventors:
Edward H. Schuchman - Haworth NJ, US
Efrat Eliyahu - New York NY, US
Assignee:
MOUNT SINAI SCHOOL OF MEDICINE - New York NY
International Classification:
C12Q 1/34
C12Q 1/68
G01N 33/573
US Classification:
435 618, 435 18, 435 71
Abstract:
The present invention relates to a method of predicting the likelihood of embryo or oocyte survival. This method involves providing a sample of an embryo, an oocyte, or surrounding liquid or cells, and screening the sample for ceramidase expression or activity. The ceramidase expression or activity obtained through said screening is then correlated to a prediction of the likelihood of embryo or oocyte survival. Also disclosed is a kit.

Method To Determine Embryo And Oocyte Quality Based On Ceramidase

View page
US Patent:
20130280717, Oct 24, 2013
Filed:
Jun 20, 2013
Appl. No.:
13/922995
Inventors:
Efrat Eliyahu - New York NY, US
International Classification:
G01N 33/68
US Classification:
435 611, 435 18, 435 74
Abstract:
The present invention relates to a method of predicting the likelihood of embryo or oocyte survival. This method involves providing a sample of an embryo, an oocyte, or surrounding liquid or cells, and screening the sample for ceramidase expression or activity. The ceramidase expression or activity obtained through said screening is then correlated to a prediction of the likelihood of embryo or oocyte survival. Also disclosed is a kit.

Acid Ceramidase And Cell Survival

View page
US Patent:
20080199450, Aug 21, 2008
Filed:
Jan 7, 2008
Appl. No.:
11/970393
Inventors:
Edward H. SCHUCHMAN - Haworth NJ, US
Efrat ELIYAHU - New York NY, US
Xingxuan HE - Fresh Meadows NY, US
Assignee:
MOUNT SINAI SCHOOL OF MEDICINE - New York NY
International Classification:
A61K 38/50
C12N 5/08
C12Q 1/37
A61P 15/00
US Classification:
424 946, 435375, 435 18
Abstract:
The present invention relates to methods of promoting the survival of cells by treating the cells with acid ceramidase. A kit for promoting ex vivo cell survival is also disclosed, as is a method of predicting in vitro fertilization outcome of a female subject.
Control profile
Efrat Eliyahu from New York, NY, age ~52 Get Report